Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth.
Kim W, Lee S, Kim HS, Song M, Cha YH, Kim YH, Shin J, Lee ES, Joo Y, Song JJ, Choi EJ, Choi JW, Lee J, Kang M, Yook JI, Lee MG, Kim YS, Paik S, Kim HH.
Kim W, et al. Among authors: kim yh, kim hh, kim ys, kim hs.
Genome Res. 2018 Mar 1;28(3):374-382. doi: 10.1101/gr.223891.117.
Genome Res. 2018.
PMID: 29326299
Free PMC article.